Bis(5-bromoindol-3-yl)(4-chlorophenyl)methane (3g) 17
3,3¢-(Phenylmethylene)bis(1H-indole) (3a)
Pink solid; mp 122–124 ◦C; 1H NMR (400 MHz, CDCl3): d 7.91
(br s, 2H, NH), 7.34–7.39 (m, 6H), 7.25–7.29 (m, 2H), 7.14–7.17
(m, 3H), 7.00 (t, J = 6.8 Hz, 2H), 6.66 (s, 2H), 5.88 (s, 1H, Ar–
CH); 13C NMR (50 MHz, CDCl3): d 144.2, 136.9, 128.9, 128.4,
127.3, 126.3, 123.8, 122.1, 120.1, 120.0, 119.5, 111.2, 40.4; IR
(KBr) nmax/cm-1 3410, 3051, 2924, 2858, 1612; HRMS (El) calcd
for C23H18N2: 322.1470; found 322.1472.
Pink solid; mp 212–214 ◦C; 1H NMR (400 MHz, CDCl3) d
8.02 (br s, 2H), 7.44 (s, 2H), 7.18–7.24 (m, 8H), 6.59(d, J =
1.6 Hz, 2H), 5.71 (s, 1H) 13C NMR (50 MHz, CDCl3): d 141.8,
135.5, 132.4, 130.1, 128.8, 128.7, 125.3, 125.1, 122.4, 118.7, 113.0,
39.5. IR nmax/cm-1 3431, 3130, 2856, 1616; HRMS (El) calcd for
C23H15Br2ClN2: 511.9291; found 511.9297.
Bis(5-methylindol-3-yl)(4-chlorophenyl)methane (3h)
Pink solid; mp 148–150 ◦C; 1H NMR (400 MHz, CDCl3): d 7.78
(br, s, 2H, NH), 7.21–7.23 (m, 6H), 7.15 (s, 2H), 7.00 (d, J = 8.8 Hz,
2H), 6.54 (s, 2H), 5.78 (s, 1H, Ar–CH), 2.35 (s, 6H, CH3); 13C
NMR (50 MHz, CDCl3): d 143.0, 135.2, 131.9, 130.3, 128.8, 128.6,
127.3, 124.1, 123.9, 119.6, 119.0, 111.0, 39.7, 21.7. IR nmax/cm-1
3408, 3026, 2922, 2858, 1622; HRMS (El) calcd for C25H21N2Cl:
384.1393; found 384.1389.
Bis(6-chloroindol-3-yl)(phenyl)methane (3b)
Pink solid; mp 128–130 ◦C; 1H NMR (200 MHz, CDCl3): d 7.96
(br s, 2H, NH), 7.34 (s, 2H), 7.28–7.30 (m, 4H), 7.23–7.26 (m,
3H), 6.96 (d, J = 8.4 Hz, 2H), 6.61 (s, 2H), 5.78 (s, 1H, Ar–CH);
13C NMR (50 MHz, CDCl3): d 143.5, 137.2, 128.8, 128.6, 128.2,
126.7, 125.8, 124.3, 120.9, 120.3, 119.8, 111.2, 40.3. IR nmax/cm-1
3423, 3026, 2927, 2858, 1610; HRMS (El) calcd for C23H16N2Cl2:
390.0691; found 390.0694.
Bis(5-bromoindol-3-yl)(3-methylphenyl)methane (3i)
◦
1
Bis(6-fluoroindol-3-yl)(phenyl)methane (3c)
Pink solid; mp 155–157 C; H NMR (400 MHz, CDCl3): 7.97
(br, s, 2H, NH); 7.47 (s, 2H), 7.14–7.23 (m, 6H), 7.09 (s, 1H), 7.02–
7.05 (m, 3H), 6.58 (s, 2H), 5.68 (s, 1H, Ar–CH), 2.28 (s, 3H, CH3);
13C NMR (50 MHz, CDCl3): d 143.2, 138.2, 135.5, 129.5, 128.9,
128.5, 127.6, 125.8, 125.1, 125.0, 122.5, 119.3, 112.8, 40.0, 21.8.
IR nmax/cm-1 3421, 3024, 2922, 2864, 1602; HRMS (El) calcd for
C24H18N2Br2: 491.9837; found 491.9840.
Pink solid; mp 133–135 ◦C; 1H NMR (400 MHz, CDCl3): d 7.87
(br, s, 2H, NH), 7.19–7.31 (m, 7H), 6.98–7.00 (dd, J = 1.8, 9.8 Hz,
2H), 6.74(dt, J = 2.0, 9.2 Hz, 2H), 6.58 (s, 2H), 5.78 (s, 1H, Ar–
CH); 13C NMR (50 MHz, CDCl3): d 162.5, 157.8, 143.8, 136.9,
136.7, 128.8, 128.6, 126.6, 124.0, 123.9, 123.8, 120.9, 120.7, 119.8,
108.5, 108.0, 97.8, 97.3, 40.4. IR nmax/cm-1 3421, 3064, 3030, 2929,
1624; HRMS (El) calcd for C23H16N2F2: 358.1282; found 358.1284.
Bis(6-fluoroindol-3-yl)(3-methylphenyl)methane (3j)
Pink solid; mp 141–143 ◦C; 1H NMR (400 MHz, CDCl3): d 7.88
(br, s, 2H, NH), 7.23–7.27 (m, 2H), 7.14–7.18 (m, 2H), 7.09 (d,
J = 8.0 Hz, 1H), 6.98–7.03 (m, 3H), 6.75 (dt, J = 1.2, 9.1 Hz, 2H),
6.60 (s, 2H), 5.75 (s, 1H, Ar–CH), 2.28 (s, 3H, CH3); 13C NMR
(50 MHz, CDCl3): d 162.5, 157.8, 143.7, 138.1, 136.9, 136.6, 129.6,
128.4, 127.4, 125.8, 124.0, 123.8, 120.9, 120.7, 119.9, 108.5, 108.0,
97.8, 97.3, 40.3, 21.8. IR nmax/cm-1 3419, 3061, 2920, 2858, 1624;
HRMS (El) calcd for C24H18N2F2: 372.1438; found 372.1435.
Bis(5-methylindol-3-yl)(phenyl)methane (3d)15
Red solid; mp 193–194 ◦C; 1H NMR (400 MHz, CDCl3): d 7.74
(br, s, 2H, NH), 7.32 (d, J = 7.2 Hz, 2H), 7.26 (t, J = 7.2 Hz,
2H), 7.20–7.22 (m, 3H), 7.18 (s, 2H), 6.98 (d, J = 8.0 Hz, 2H),
6.54 (s, 2H), 5.81 (s, 1H, Ar–CH); 13C NMR (50 MHz, CDCl3): d
144.4, 135.3, 128.9, 128.7, 128.4, 127.5, 126.3, 124.1, 123.8, 119.7,
119.5, 110.9, 40.3, 21.7. IR nmax/cm-1 3408, 3022, 2920, 2856, 1597;
HRMS (El) calcd for C25H22N2: 350.1783; found 350.1786.
Bis(5-methylindol-3-yl)(3-methylphenyl)methane (3k)
Bis(indol-3-yl)(4-chlorophenyl)methane (3e) 16
Pink solid; mp 140–142 ◦C; 1H NMR (400 MHz, CDCl3): d 7.70
(br, s, 2H, NH), 7.09–7.21 (m, 8H), 6.96–7.01 (m, 2H), 6.52 (s,
2H), 5.77 (s, 1H, Ar–CH), 2.34 (s, 6H, CH3), 2.27 (s, 3H, CH3);
13C NMR (50 MHz, CDCl3): d 144.3, 137.8, 135.2, 129.7, 128.6,
128.3, 127.6, 127.1, 125.9, 124.1, 123.7, 119.7, 110.9, 40.1, 21.8,
21.7. IR nmax/cm-1 3408, 3022, 2918, 2858, 1601; HRMS (El) calcd
for C26H24N2: 364.1940; found 364.1945.
◦
1
Pink solid; mp 76–77 C; H NMR (400 MHz, CDCl3): d 7.88
(br, s, 2H, NH), 7.35 (t, J = 7.2 Hz, 4H), 7.21–7.27 (m, 4H), 7.17
(t, J = 7.4 Hz, 2H), 7.01 (t, J = 7.4 Hz, 2H), 6.61 (s, 2H), 5.85 (s,
1H, Ar–CH); 13C NMR (50 MHz, CDCl3): d 142.8, 136.9, 132.0,
130.3, 128.6, 127.1, 123.8, 122.3, 120.1, 119.6, 119.4, 111.4, 39.8.
IR nmax/cm-1 3410, 3051, 2923, 2858, 1614; HRMS (El) calcd for
C23H17ClN2: 356.1080; found 356.1075.
Acknowledgements
Bis(6-fluoroindol-3-yl)(4-chlorophenyl)methane (3f)
This work was financially supported by the Natural Science
Foundation of Zhejiang Province for founding (No. Y406049).
◦
1
Pink solid; mp 98–100 C; H NMR (400 MHz, CDCl3): d 7.94
(br, s, 2H, NH), 7.21–7.24 (m, 6H), 7.02 (d, J = 9.6 Hz, 2H), 6.77
(dt, J = 1.1, 9.2 Hz, 2H), 6.60 (s, 2H), 5.77 (s, 1H, Ar–CH); 13C
NMR (50 MHz, CDCl3): d 162.6, 157.8, 142.3, 136.9, 136.7, 132.3,
130.2, 128.7, 124.1, 124.0, 123.6, 120.8, 120.6, 119.3, 108.7, 108.2,
98.0, 97.4, 39.8. IR nmax/cm-1 3427, 3066, 2864, 1624; HRMS (El)
calcd for C23H15F2ClN2: 392.0892; found 392.0892.
Notes and references
1 (a) K. Godula and D. Sames, Science, 2006, 312, 67–72; (b) R. G.
Bergman, Nature, 2007, 446, 391–393; (c) J.-Y. Cho, M. K. Tse, Holmes,
R. E. Jr. Maleczka and M. R. Smith, III, Science, 2002, 295, 305–308;
(d) H. Chen, S. Schlecht, T. C. Semple and J. F. Hartwig, Science, 2000,
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 2975–2978 | 2977
©